Earnings Call Intelligence Subscribe
Home › Call Sheets › A › Q3'26
Call sheet · Q3'26

Agilent Technologies (A)

Q3'26 earnings call · held August 26, 2026 · compared with the Q2'26 call · management-credibility review
7/12
Disclosure score
2 medium, 2 low flags
Financial quality
Bottom line
The market will focus on the 7.3% revenue beat, but the real story is the $60 M order funnel behind the new 9500 ICP‑MS and the looming Train C capacity constraint that won’t materialize until 2027. While pricing and Ignite continue to lift margins, the binding constraint is the still‑unfilled CDMO capacity and a rising leverage ratio that could bite if growth stalls. If the 9500 pipeline dries up or Train C delays, the EPS upside evaporates.

The 30-second version

  • Sleeper story: 9500 ICP‑MS pipeline builds $60 M funnel while LC/GC growth stays modest
  • Headline beat masks a near‑term CDMO capacity lag
  • Red flag: DSO metric vanished, AI supply‑chain story lacks numbers

What changed this quarter

MetricQ2'26Q3'26Change
Revenue (core YoY)$1.83 B, +6.3% YoY$1.88 B, +7.3% YoY+5 bps acceleration
Operating margin ex‑tariff26.4%27.2%+80 bps expansion
Gross margin ex‑tariff55.0%54.9%-10 bps dip
EPS (ex‑tariff)$1.49$1.56+7 cents (+5%)
Operating cash flow$277 M$519 M+88% surge
CapEx$76 M$80 M+5% increase
Net leverage0.7×1.0×Leverage up but still modest
Book‑to‑bill≈1.0 (Q2)>1.0 for 10th straight quarterContinues strong order flow
Advanced Therapeutics (CDMO) growthHigh‑single‑digit Q2≈30% Q3Accelerated specialty CDMO growth

Accountability tracked

2 new promises made1 prior promise scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full A Q3'26 report Subscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.